Pain after thoracotomy is considered to be severe and contributes to respiratory and cardiovascular complications. 1 -4 Thoracic epidural analgesia provides optimal analgesia with a minimum impairment of the respiratory function and decreases postoperative morbidity and mortality. 5 Levobupivacaine is a long-acting, amide-type local anaesthetic. Preclinical animal studies comparing levobupivacaine with either the dextro enantiomer alone or together with the racemate suggested that it is less neuro and cardiotoxic than either of these. 6 7 Levobupivacaine is metabolized in the liver, primarily by the cytochrome P450. Clearance is reduced when the hepatic function is damaged. The mechanism of action is exactly the same as that of racemic bupivacaine, blocking the sodium channels in the resting position.
To our knowledge, only one study has investigated the use of levobupivacaine and sufentanil in post-thoracotomy analgesia. 8 In addition, the debate regarding the relative effects of volume and concentration of the local anaesthetic solution used for epidural analgesia remains unresolved. 9 -12 Therefore, the aim of our study was to determine the incidence of side-effects [in particular changes in arterial pressure, postoperative nausea or vomiting (PONV), pruritus] during continuous thoracic epidural infusion using three different concentrations of levobupivacaine and sufentanil whereby a similar total dose per hour was administered. Secondarily, we evaluated sensory and motor block, pain score, analgesic rescue dose, sedation, and patient satisfaction.
Methods
This study was designed as a prospective, randomized, and double-blinded investigation. Approval by the local ethics committee was obtained and written informed consent was given by each patient enrolled in the study.
One hundred and fifty consecutive patients undergoing elective thoracic surgery were randomly assigned to one of the three groups. All patients underwent a muscle-sparing postero-lateral thoracotomy in the fifth intercostal space and were operated by the same surgeon between March 2006 and March 2007 in the 'Maggiore della Carità Hospital' in Novara (Italy). Exclusion criteria were sepsis; allergy to amide-type local anaesthetics, opioids, or both; opioid addiction; coagulopathy and administration of anticoagulant medication; renal disease; liver disease; neurologic disease; and forced vital capacity (FVC), forced expiratory volume in the first second (FEV 1 ), carbon monoxide lung diffusion capacity (DLCO) ,60% of normal value.
One hour before anaesthesia, patients were premedicated with midazolam 1-2 mg i.v. and atropine 0.01 mg kg 21 i.v. In the operating theatre, after the administration of 500 ml of Ringer's acetate solution i.v., a 20 gauge epidural catheter was inserted through an 18 gauge Tuohy needle into the epidural space between T4 and T7 using a loss of resistance technique. The epidural catheter was directed cephalad for a distance of 4-5 cm and fixed in place. After an aspiration test for blood and cerebrospinal fluid that yielded negative results, a test dose with lidocaine 2% (3 ml) was injected through the catheter and the patient was then placed in the supine position. General anaesthesia was induced with droperidol 1 The infusion of levobupivacaine/sufentanil mixture was continued until the third postoperative day. VAS score at rest, on coughing (VASc), and patient satisfaction (defined as optimal, good, sufficient, and insufficient) after surgical operation (day 0), on the first, second, and third postoperative days (days 1, 2, and 3) were independently measured by a trained physician blinded to the randomization and experimental results. The incidence of side-effects such as pruritus, nausea, vomiting, and sedation was also recorded. Nausea and vomiting were treated with ondansetron 4 mg and pruritus with low dosage of naloxone 0.1 mg as required.
Non-invasive arterial pressure, heart rate, and ventilatory frequency were measured every 15 min with a Holter (Tonoport V, General Electric). At breakfast, lunch, and evening, there was an interruption to rest the arm for about 45 min. A hypotension event was defined as a decrease in systolic arterial pressure below 90 mm Hg lasting for at least two consecutive measurements in an hour. Should a symptomatic hypotensive event occur, a rapid infusion of 200 ml of colloid would be administered. If bradypnoea (ventilatory frequency ,10 bpm) and sedation score of 4 occurred, the epidural infusion would be stopped, intensive monitoring instituted, respiratory depression treated appropriately, and the patient excluded from the study.
Sedation was recorded on a four-point scale: 1, oriented conversation; 2, confused conversation; 3, inappropriate conversation; and 4, severe sedation, no conversation.
Motor block was assessed according to a modified Bromage scale: 0, no motor block; 1, inability to raise extended legs; 2, inability to flex knees; and 3, inability to flex ankle joints. 13 
Statistical analyses
The number of patients included in the study was based on the study by Dernedde and colleagues 9 assuming a power level of 0.80, a multiple comparison test at a 0.05 significance level (0.0166 for each comparison), and a difference of means of systolic arterial pressure between the most different groups equal to 10 mm Hg (DS 10).
Analysis of variance (ANOVA) was performed in order to identify the differences among the three treatment groups in the variables: systolic blood age, weight, height, FEV1%, DLCO%, pressure, and the heart rate on preoperative days, duration of hospitalization, VAS values, and bolus infusions. If data were not normally distributed, logarithmic or square-root transformations were used to normalize the data. Non-parametric Kruskal-Wallis test was used, if the assumption of normality underlying ANOVA was violated.
ANOVA for repeated measurements was used to assess the differences in systolic, diastolic arterial pressure, VAS values, bolus infusions, and in heart rate on the first, second, and third postoperative days. This method of analysis was used because of the multiple responses taken in sequence (surgery day, the first, second, and third postoperative days) on each experimental unit. The objective was to examine and compare response trends over time, comparing treatments averaged over time, and comparing measurement time within a treatment. The unstructured (UN) covariance matrix was used as a correlation pattern among responses on the same subject. The model used in this analysis was m ik ¼mþa i þd k þ(ad) ik , where m is the overall mean, a the 'group effect', d the 'time effect', and (ad) the 'groupÂtime effect'.
14 The association between side-effects during the postoperative days and the group of treatment was evaluated using the x 2 test. The values on the surgery day have not been considered in order to analyse the same number of measures for all patients as they were repeated according to clinical need. P-values were considered to be statistically significant when ,0.05. SAS software (Release 8.2, by SAS Institute Inc., Cary, NC, USA) was used to perform all statistical analyses.
Results

Patients
One hundred and fifty patients, aged 18 -80 yr, with ASA physical status II or III, undergoing elective thoracic surgery were randomly assigned to one of the three groups according to the different concentration of levobupivacaine in the continuous thoracic epidural infusion (i.e. 0.5%, 0.25%, or 0.15%) maintaining a total dose of levobupivacaine at 10 mg h 21 and sufentanil at 2.6 mg h 21 after thoracotomy.
The analysis included 138 out of 150 subjects entered into the study. Twelve patients, equally distributed among the groups, were excluded for: accidental removal of the catheter (n¼1), re-operation for postoperative bleeding (n¼1), re-operation for postoperative intestinal obstruction (n¼1), and for incomplete data (n¼9).
No significant differences were found in patient characteristic data, haemodynamic and respiratory parameters, level of insertion of the epidural catheter (T4 -T7), and number of days of hospitalization ( Table 1 ). The level of sedation was 1 (oriented conversation) in all groups for the entire study period (data not shown).
Quality of analgesia
In post-thoracotomy patients, the mixture of levobupivacaine and sufentanil resulted in a good pain control in all groups. Mean values of VAS score at rest and on coughing were inferior to 2 and 3, respectively ( Table 2) . No difference was found in VAS score at rest and on coughing in the three groups. Their levels were higher in the first when compared with the third postoperative day, independently from the treatment ( Table 2) .
No significant difference in the number of PCEA boluses was found among the three groups; on the first postoperative day, patients needed more epidural boluses than on the subsequent days ( Table 2) . Patient satisfaction for the analgesia received during all the time points considered was good or higher in 91%, 96%, and 93% of the patients treated, respectively, for Groups 1, 2, and 3 (data not shown). No patients received tramadol during the first 3 postoperative days.
Side-effects
No difference in mean systolic or diastolic pressure has been found between the groups during the 3 postoperative days. In the group treated with levobupivacaine at 0.5%, 19% of the subjects had at least one hypotensive event and 22% of the subjects in the 0.25% and 0.15% groups, respectively (Table 3) . Neither drug medication nor colloid infusion was necessary to support arterial pressure in any group as, during the hypotensive events, patients were not symptomatic. In the group treated with levobupivacaine at 0.5%, the incidence of nausea and vomiting was 19% and 4%, respectively. In the group treated with levobupivacaine at 0.25%, 15% of the patients experienced at least one episode of nausea and 9% of vomiting. In the last group instead nausea and vomiting occurred in 22% and 13% of the cases, respectively (Table 3) . About 40% of all patients, equally distributed among the groups, had at least one episode of pruritus. No medical treatment was needed. Postoperative bradycardia, bradypnoea, sensitive, or motor block did not occur (data not shown).
Discussion
Our main finding is that, in patients admitted for thoracic surgery, the continuous epidural infusion of levobupivacaine and sufentanil mixture in three different volumes and concentrations determines an equal incidence of side-effects, primarily changes in arterial pressure and also nausea, vomiting, and pruritus. Furthermore, our study confirms that good quality analgesia in post-thoracotomy patients can be obtained using a continuous epidural infusion of a mixture of levobupivacaine at 10 mg h 21 and sufentanil at 2.6 mg h 21 based on our clinical experience. These results are in line with previous studies, supporting the view that the quality of epidural analgesia depends on the total dosage of local anaesthetic and not on the volume or concentration. 9 15-17 To our knowledge, clinical studies evaluating the use of levobupivacaine and sufentanil in post-thoracotomy patients are very limited and, particularly, our study is the first large prospective, randomized, and double-blinded clinical trial that investigated the volume-concentration issue with these drugs. 8 We selected levobupivacaine at 10 mg h 21 and sufentanil at 2.6 mg h 21 after taking into consideration the previous experiences. In a study by Dernedde and colleagues, 10 levobupivacaine alone at 15 mg h 21 provided a good postoperative analgesia after abdominal surgery. In thoracic surgical patients, Snijdelaar and colleagues 11 used a small amount of bupivacaine (7.5-10 mg h
21
) and sufentanil 4-5.6 mg h 21 obtaining a good pain control. In our study, we tried to minimize the side-effects by reducing the doses of both local anaesthetic and opioid in order to exploit their documented synergy. 18 The three different concentrations used were equally effective with respect to pain control (VAS and VASc), with no difference in PCEA request.
Contrary to previous studies, we found that there was no need for i.v. opioids to control postoperative pain. This was probably the result of PCEA use. 8 -10 Side-effects related to the administration of local anaesthetics in continuous thoracic epidural infusion are thought to be related to thoracic sympathetic block causing hypotension and bradycardia. 19 In our study, we found that levobupivacaine (10 mg h 21 ) produced a low incidence of hypotensive episodes (around 21%) and no bradycardia, with no between-group differences.
Sufentanil is an ideal drug for metameric administration as it is highly liposoluble with minimal rostral diffusion; however, its optimal concentration has not yet been fully determined. 8 ). 8 11 20-22 In our study, the overall incidence of nausea and vomiting in the 3 postoperative days was comparable with the study by Snijdelaar and colleagues, 11 but analysing separately per day, PONV occurred less frequently in our patients and predominantly on the first postoperative day (data not shown). This is probably related to a lower dose of sufentanil administered, as in both studies droperidol was used at the induction and nasogastric tube was not inserted. The use of epidural opioids increases the incidence of pruritus. In fact, in our study, mild pruritus was present in 40% of patients with no differences among the groups. Despite this high percentage, no patients required any treatment.
One limitation of our study is that the use of analgesic medication other than those administered via the epidural catheter (ketorolac 60 mg day 21 and acetaminophen 1.5 g day 21 ) might be a bias in interpreting our data. Since from our experience the vast majority of these patients suffer from shoulder pain, which is unresponsive to epidural analgesia, we felt obliged to introduce these treatments in the protocol. 23 In conclusion, our study suggested that the use of three different concentrations of a continuous thoracic epidural administration of levobupivacaine at 10 mg h 21 and sufentanil at 2.6 mg h 21 was associated with an equal incidence of side-effects and, secondarily, with a good pain control at rest and after coughing in post-thoracotomy patients. This suggests that the total dose delivered per hour was the primary determinant for the side-effects and the analgesic propriety and not the concentration or volume infused.
